TKNO · Alpha Teknova, Inc.
Market Cap
$388.70M
Shares
53.69M
TKNO metrics
65 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$6.92
Market cap
$388.70M
Price action
19 metricsPrice change (1W)
-2.8%
Price change (30D)
+6.0%
Price change (3M)
+51.8%
Price change (6M)
+228.0%
Price change (YTD)
+82.1%
Price change (1Y)
+63.2%
Trailing year
Price change (5Y)
-63.5%
52-week high
$7.46
52-week low
$1.99
Change from 52-week high
-7.2%
Change from 52-week low
+247.7%
Annualized volatility
80.6%
Beta
1.4
RSI (14D)
52.7
Price vs SMA 50
+12.8%
Price vs SMA 200
+64.3%
Avg volume (3M)
210,453
Relative volume
0.7
Average dollar volume
$1.27M
Company
3 metricsSector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
53.69M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
8.9×
reciprocal yield 11.2%
P / book
6.2
reciprocal yield 16.1%
FCF yield
-1.9%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-4.3%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
5.3×
reciprocal yield 19.0%
EV / revenue historical average (5Y)
4.6×
reciprocal yield 21.7%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-05
Profitability
9 metricsGross margin
34.6%
Operating margin
-36.2%
Trailing 12 months
Net margin
-38.4%
Gross profit (TTM)
$15.12M
Operating profit (TTM)
−$15.81M
Net income (TTM)
−$16.77M
Trailing 12 months
Diluted EPS (TTM)
$-0.30
FCF margin
-16.8%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+18.5%
Year over year
Net income growth YoY
—
Revenue (TTM)
$43.70M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.3%
Year over year · more shares
Revenue CAGR (3Y)
-0.7%
Revenue CAGR (5Y)
+5.3%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-26.8%
Return on assets
-17.5%
Debt / equity
—
Current ratio
4.5
EBITDA (TTM)
−$9.47M
Free cash flow (TTM)
−$7.35M
Quick ratio
3.5
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$6.00M
Total assets
$95.88M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$6.27M
Capital expenditures (TTM)
$1.08M
R&D (TTM)
$2.23M
SG&A (TTM)
—
Stock compensation (TTM)
$2.94M
R&D / revenue
5.1%
Stock compensation / revenue
6.7%
Ownership (13F)
3 metrics13F filers
80
13F filer change QoQ
+2
Institutional ownership
17.0%
Short interest
3 metricsShort interest
3.0%
Latest settlement · 5.0 days to cover
Days to cover
5.0d
Short-squeeze score
68 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1850902
CUSIP
02080L102
13F (30d)
56 filings
56 filers
Visit website
Investor relations